C. Fuhrman, «Le syndrome d'apnées du sommeil en France: un syndrome fréquent et sousdiagnostiqué, pp.44-45

T. Young, «The occurence of sleep-disordered breathing among middle-aged adults.,» The new england journal of medecine, pp.1230-1235, 1993.

P. Escourrou, Quelle approche clinique et quelle proc??dure diagnostique pour le SAHOS ?, Revue des Maladies Respiratoires, vol.27, pp.115-123, 2010.
DOI : 10.1016/S0761-8425(10)70017-6

J. Hung, «Association of sleep apnoea with myocardial infarction in men,» The Lancet, pp.261-264, 1990.

R. S. Leung and . Cardiovascular-disease, Sleep Apnea and Cardiovascular Disease, American Journal of Respiratory and Critical Care Medicine, vol.22, issue.12, pp.2147-2165, 2001.
DOI : 10.1097/00063198-199511000-00014

R. L. Drake, Gray's -Anatomie pour les étudiants, 2006.

A. Pinto, Revisiting Cardiac Cellular CompositionNovelty and Significance, Circulation Research, vol.118, issue.3, pp.400-409, 2016.
DOI : 10.1161/CIRCRESAHA.115.307778

URL : http://circres.ahajournals.org/content/circresaha/118/3/400.full.pdf

C. Kholer and . «université-médicale-virtuelle-francophone, [En ligne] Available: http://campus.cerimes.fr/histologie-et-embryologie- medicales/enseignement, 2010.

C. A. Walker, «The structure and fonction of the cardiac myocyte : a review of fundamental concepts,» The journal of thoracic and cardiovascular surgery, pp.375-382, 1999.

J. Lanner, Ryanodine Receptors: Structure, Expression, Molecular Details, and Function in Calcium Release, Cold Spring Harbor Perspectives in Biology, vol.2, issue.11, pp.1-21, 2010.
DOI : 10.1101/cshperspect.a003996

M. Michalak, Endoplasmic and sarcoplasmic reticulum in the heart, Trends in Cell Biology, vol.19, issue.6, pp.253-259, 2009.
DOI : 10.1016/j.tcb.2009.03.006

A. Wagner, «Evolution de la maladie coronaire en France de, Bulletin épidémiologique hebdomadaire, pp.415-419, 2000.

«. Inserm and . Février, Available: https://inserm.fr/thematiques/physiopathologie-metabolisme-nutrition/dossiers-dinformation/atherosclerose, 2014.

P. Golstein, «Cell death by necrosis : towards a molecular definition,» Trends in biochemical sciences, pp.37-43, 2006.

J. D. Mccully, Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury, AJP: Heart and Circulatory Physiology, vol.286, issue.5, pp.1923-1935, 2004.
DOI : 10.1152/ajpheart.00935.2003

R. Taylor, «Apoptosis : controlled demolition at the cellular level,» Nature review - Molecular cell biology, pp.231-241, 2008.

M. Ovize, «Postconditionning and protection from reperfusion injury : where do we stand?,» Cardiovascular research, pp.406-423, 2010.

B. Redfors, «Myocardial infarct size and area at risk assessment in mice, Exp Clin Cardiol, vol.17, pp.268-272, 2012.

D. Glogar, «Definition and significance of the area at risk in myocardial infarct and the ischemic border zone in acute myocardial infarct, Acta med austriaca, pp.1-40, 1986.

C. Seiler, The human coronary collateral circulation: development and clinical importance, European Heart Journal, vol.34, issue.34, pp.2674-2682, 2013.
DOI : 10.1093/eurheartj/eht195

URL : https://academic.oup.com/eurheartj/article-pdf/34/34/2674/17896428/eht195.pdf

M. P. Maxwell, «Species variation in the coronary collateral circulation during regional myocardial ischemia : a critical determinant of the rate of evolution and extent of myocardial infarction,» Cardiovascular research, pp.737-746, 1987.

E. Braunwald, The stunned myocardium: prolonged, postischemic ventricular dysfunction, Circulation, vol.66, issue.6, pp.1146-1149, 1982.
DOI : 10.1161/01.CIR.66.6.1146

URL : http://circ.ahajournals.org/content/circulationaha/66/6/1146.full.pdf

G. Morciano, Mechanistic Role of mPTP in Ischemia-Reperfusion Injury, Adv Exp Med Biol, vol.11, issue.Suppl 3, pp.169-189, 2017.
DOI : 10.1038/nprot.2016.064

P. M. Kang, «Morphological and molecular characterization of adult cardiomyocytes apoptosis during hypoxia and reoxygenation,» Circulation research, pp.118-125, 2000.

B. Freud, Apoptosis is Initiated by Myocardial Ischemia and Executed During Reperfusion, Journal of Molecular and Cellular Cardiology, vol.32, issue.2, pp.197-208, 2000.
DOI : 10.1006/jmcc.1999.1066

P. Lévy, «Obstructive sleep apnoea syndrome, Na. Rev. Dis. Primers, vol.1, pp.1-20, 2015.

H. Autorité and D. Santé, «Évaluation clinique et économique des dispositifs médicaux et prestations associées pour prise en charge du syndrome d'apnées hypopnées obstructives du sommeil (SAHOS) Révision de catégories homogènes de dispositifs médicaux ? Volet médico-technique, 2014.

C. Arnaud, ». Laboratoire, and . En, Available: http://hp2.ujf-grenoble.fr/lhypoxie

Y. Dauvilliers, Quelle ??valuation pr??th??rapeutique d???un patient avec SAHOS nouvellement diagnostiqu?? ?, Revue des Maladies Respiratoires, vol.27, pp.124-136, 2010.
DOI : 10.1016/S0761-8425(10)70018-8

M. Destors, Physiopathologie du syndrome d???apn??es-hypopn??es obstructives du sommeil et de ses cons??quences cardio-m??taboliques, La Presse M??dicale, vol.46, issue.4, 2017.
DOI : 10.1016/j.lpm.2016.09.008

M. Vecchierini, Strat??gie th??rapeutique du SAHOS int??grant les traitements associ??s ?, Revue des Maladies Respiratoires, vol.27, pp.166-178, 2010.
DOI : 10.1016/S0761-8425(10)70022-X

P. Lévy, Sleep apnoea and the heart, European Respiratory Review, vol.22, issue.129, pp.333-352, 2013.
DOI : 10.1183/09059180.00004513

D. Junquero, Quelle définition pour quel(s) traitement(s) ?, pp.1045-1053, 2005.
DOI : 10.1051/medsci/200521121045

N. S. Cherniack, New mechanisms for the cardiovascular effects of sleep apnea, The American Journal of Medicine, vol.109, issue.7, pp.592-594, 2000.
DOI : 10.1016/S0002-9343(00)00614-8

T. Saito, Sleep apnea in patients with acute myocardial infarction, Critical Care Medicine, vol.19, issue.7, pp.938-941, 1991.
DOI : 10.1097/00003246-199107000-00019

Y. Peker, An independent association between obstructive sleep apnoea and coronary artery disease, European Respiratory Journal, vol.14, issue.1, pp.179-184, 1999.
DOI : 10.1034/j.1399-3003.1999.14a30.x

H. Schäfer, Obstructive Sleep Apnea as a Risk Marker in Coronary Artery Disease, Cardiology, vol.92, issue.2, pp.79-84, 1999.
DOI : 10.1159/000006952

T. Mooe, «Sleep-disordered breathing and coronary artery disease. Long term prognosis, Am J Respir Crit Care Med, vol.164, 1910.

C. Lee, «Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effet o microvascular perfusion, Chest, pp.1488-1495, 2009.

E. Shahar, Sleep-disordered Breathing and Cardiovascular Disease, American Journal of Respiratory and Critical Care Medicine, vol.13, issue.1, pp.19-25, 2001.
DOI : 10.2105/AJPH.78.5.544

S. Leão, «Effect of obstructive sleep apnea in acute coronary syndrome, Am J Cardiol, pp.1084-1087, 2016.

J. Marin, Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study, The Lancet, vol.365, issue.9464, pp.1046-1053, 2005.
DOI : 10.1016/S0140-6736(05)74229-X

F. Garcia-rio, CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction, International Journal of Cardiology, vol.168, issue.2, pp.1328-1335, 2013.
DOI : 10.1016/j.ijcard.2012.12.015

J. Xie, Nocturnal Hypoxemia Due to Obstructive Sleep Apnea Is an??Independent Predictor of Poor Prognosis After Myocardial Infarction, Journal of the American Heart Association, vol.5, issue.8, pp.1-8, 2016.
DOI : 10.1161/JAHA.115.003162

M. Arzt, Sleep-Disordered Breathing and Coronary Artery Disease, Canadian Journal of Cardiology, vol.31, issue.7, pp.909-917, 2015.
DOI : 10.1016/j.cjca.2015.03.032

F. Portier, Traitement du SAHOS par ventilation en pression positive continue (PPC), Revue des Maladies Respiratoires, vol.27, pp.137-145, 2010.
DOI : 10.1016/S0761-8425(10)70019-X

B. Fleury, Traitement du SAHOS par orth??se d???avanc??e mandibulaire (OAM), Revue des Maladies Respiratoires, vol.27, pp.146-156, 2010.
DOI : 10.1016/S0761-8425(10)70020-6

M. Blumen and S. , Traitement chirurgical du SAHOS, Revue des Maladies Respiratoires, vol.27, pp.157-165, 2010.
DOI : 10.1016/S0761-8425(10)70021-8

A. Lamouroux, Compliance, observance ou adh??sion th??rapeutique : de quoi parlons-nous ?, Revue des Maladies Respiratoires, vol.22, issue.1, pp.31-34, 2005.
DOI : 10.1016/S0761-8425(05)85433-6

D. Sin, Long-term Compliance Rates to Continuous Positive Airway Pressure in Obstructive Sleep Apnea, Chest, vol.121, issue.2, pp.430-435, 2002.
DOI : 10.1378/chest.121.2.430

E. Sabate, «Adherence to long-term therapies : Evidence for action,» World Health Organisation, 2003.

T. Giles, «Continuous positive airways pressure for obstructive sleep apnoea in adults,» The cochrane Database of Systematic Reviews, 2006.

N. Mcardle, Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome, American Journal of Respiratory and Critical Care Medicine, vol.14, issue.4, pp.1108-1114, 1999.
DOI : 10.1016/S0140-6736(94)91522-9

W. Mcnicholas, Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough?, European Respiratory Journal, vol.10, issue.5, pp.969-970, 1997.
DOI : 10.1183/09031936.97.10050969

F. Campos-rodriguez, Cardiovascular Mortality in Women With Obstructive Sleep Apnea With or Without Continuous Positive Airway Pressure Treatment, Annals of Internal Medicine, vol.156, issue.2, pp.115-122, 2012.
DOI : 10.7326/0003-4819-156-2-201201170-00006

N. Buchner, Continuous Positive Airway Pressure Treatment of Mild to Moderate Obstructive Sleep Apnea Reduces Cardiovascular Risk, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.12, pp.1274-1280, 2007.
DOI : 10.1378/chest.121.2.430

F. Garcia-rio, CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction, International Journal of Cardiology, vol.168, issue.2, pp.1328-1335, 2013.
DOI : 10.1016/j.ijcard.2012.12.015

A. Cassar, Treatment of Obstructive Sleep Apnea Is Associated With Decreased Cardiac Death After Percutaneous Coronary Intervention, Journal of the American College of Cardiology, vol.50, issue.14, pp.1310-1314, 2007.
DOI : 10.1016/j.jacc.2007.06.028

S. Saarelainen, Circulating Endothelin-1 in Obstructive Sleep Apnea, Endothelium, vol.322, issue.2, pp.115-118, 1997.
DOI : 10.1016/0196-9781(89)90117-4

W. Jordan, Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure, Peptides, vol.26, issue.9, pp.1654-1660, 2005.
DOI : 10.1016/j.peptides.2005.02.012

X. Yang, «Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention : A meta-analysis of randomized controlled trials,» 17 Mars 2017. [En ligne] Available: https://www.nature.com/articles/srep44789

M. Dematteis, Cardiovascular Consequences of Sleep-Disordered Breathing: Contribution of Animal Models to Understanding of the Human Disease, ILAR Journal, vol.50, issue.3, pp.262-281, 2009.
DOI : 10.1093/ilar.50.3.262

J. A. Neubauer, «Physiological and pathoshysiological responses to intermittent hypoxia, J Appl Physiol, vol.90, pp.1593-1599, 2001.

J. Garvey, Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation, European Respiratory Journal, vol.33, issue.5, pp.1195-1205, 2009.
DOI : 10.1183/09031936.00111208

P. Ferdinandy, Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning, Pharmacological Reviews, vol.59, issue.4, pp.418-458, 2007.
DOI : 10.1124/pr.107.06002

C. Murry, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation, vol.74, issue.5, pp.1124-1236, 1986.
DOI : 10.1161/01.CIR.74.5.1124

D. J. Hausenloy, Preconditioning and postconditioning: Underlying mechanisms and clinical application, Atherosclerosis, vol.204, issue.2, pp.334-341, 2009.
DOI : 10.1016/j.atherosclerosis.2008.10.029

P. Balkova, «N-acetylcysteine tractment prevents the up-regulation of MnSOD in chronically hypoxic rat hearts, Physiol Res, vol.60, pp.467-474, 2011.

F. Kolar, Role of oxidative stress in PKC-?? upregulation and cardioprotection induced by chronic intermittent hypoxia, AJP: Heart and Circulatory Physiology, vol.292, issue.1, pp.224-230, 2007.
DOI : 10.1152/ajpheart.00689.2006

H. Ma, Exchanger in Developing Rats, Cellular Physiology and Biochemistry, vol.34, issue.2, pp.313-324, 2014.
DOI : 10.1159/000363001

J. Neckar, Effects of mitochondrial KATP modulators on cardioprotection induced by chronic high altitude hypoxia in rats, Cardiovascular Research, vol.55, issue.3, pp.567-575, 2002.
DOI : 10.1016/S0008-6363(02)00456-X

J. Neckar, Increased expression and altered subcellular distribution of PKC-?? in chronically hypoxic rat myocardium: involvement in cardioprotection, AJP: Heart and Circulatory Physiology, vol.288, issue.4, pp.1566-1572, 2005.
DOI : 10.1152/ajpheart.00586.2004

J. Neckar, «Myocardial infarct size-limiting effect of chronic hypoxia persists for five weeks of normoxic recovery, Physiol Res, vol.53, pp.621-628, 2004.

H. Wang, Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation, Apoptosis, vol.62, issue.8, pp.1453-1460, 2006.
DOI : 10.1161/01.RES.87.3.241

G. Serviddio, Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion, The FASEB Journal, vol.19, issue.3, pp.354-361, 2005.
DOI : 10.1096/fj.04-2338com

H. Sun, Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload, AJP: Heart and Circulatory Physiology, vol.288, issue.4, pp.1900-1908, 2005.
DOI : 10.1152/ajpheart.01244.2003

URL : http://ajpheart.physiology.org/content/ajpheart/288/4/H1900.full.pdf

S. Buchner, Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction, European Heart Journal, vol.35, issue.3, pp.192-199, 2014.
DOI : 10.1093/eurheartj/eht450

E. Belaidi, Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications, Pharmacology & Therapeutics, vol.168, pp.1-11, 2016.
DOI : 10.1016/j.pharmthera.2016.07.010

URL : https://hal.archives-ouvertes.fr/inserm-01369186

M. Joyeux-faure, Chronic intermittent hypoxia increases infarction in the isolated rat heart, Journal of Applied Physiology, vol.98, issue.5, pp.1691-1696, 2005.
DOI : 10.1152/japplphysiol.01146.2004

H. Yeung, Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats, Journal of Pineal Research, vol.16, issue.Suppl 6, pp.12-25, 2015.
DOI : 10.1016/j.tcm.2006.02.001

L. Lavie, Obstructive sleep apnoea syndrome ??? an oxidative stress disorder, Sleep Medicine Reviews, vol.7, issue.1, pp.35-51, 2003.
DOI : 10.1053/smrv.2002.0261

M. Yamauchi, Oxidative Stress in Obstructive Sleep Apnea, Chest, vol.127, issue.5, pp.1674-1679, 2005.
DOI : 10.1378/chest.127.5.1674

T. Kietzmann, Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression, Seminars in Cell & Developmental Biology, vol.16, issue.4-5, pp.474-486, 2005.
DOI : 10.1016/j.semcdb.2005.03.010

Z. Chen, Overexpression of MnSOD Protects Against Myocardial Ischemia/reperfusion Injury in Transgenic Mice, Journal of Molecular and Cellular Cardiology, vol.30, issue.11, pp.2281-2289, 1998.
DOI : 10.1006/jmcc.1998.0789

J. Duranteau, Intracellular Signaling by Reactive Oxygen Species during Hypoxia in Cardiomyocytes, Journal of Biological Chemistry, vol.265, issue.19, pp.11619-11624, 1998.
DOI : 10.1016/0003-9861(79)90375-8

C. M. Brindeiro, Reactive oxygen species contribute to sleep apnea-induced hypertension in rats, AJP: Heart and Circulatory Physiology, vol.293, issue.5, pp.2971-2976, 2007.
DOI : 10.1152/ajpheart.00219.2007

N. Natarajan, Hypoxia Inducible Factor-1 Activation by Prolyl 4-Hydroxylase-2 Gene Silencing Attenuates Myocardial Ischemia Reperfusion Injury, Circulation Research, vol.98, issue.1, pp.133-140, 2006.
DOI : 10.1161/01.RES.0000197816.63513.27

URL : http://circres.ahajournals.org/content/circresaha/98/1/133.full.pdf

P. Totoson, Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia, Experimental Biology and Medicine, vol.27, issue.2, pp.223-232, 2013.
DOI : 10.1183/09031936.00027910

G. L. Semenza, A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation., Molecular and Cellular Biology, vol.12, issue.12, pp.5447-5454, 1992.
DOI : 10.1128/MCB.12.12.5447

R. Weidemann, Biology of HIF-1??, Cell Death and Differentiation, vol.17, issue.4, pp.621-627, 2008.
DOI : 10.1038/sj.emboj.7601300

E. Belaidi, Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat, AJP: Heart and Circulatory Physiology, vol.294, issue.2, pp.901-908, 2008.
DOI : 10.1152/ajpheart.00715.2007

S. &. Prabhakar, «HIF-1-Dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia,» Antioxydants & Redox signaling, pp.1391-1396, 2007.

E. Belaidi, Major Role for Hypoxia Inducible Factor-1 and the Endothelin System in Promoting Myocardial Infarction and Hypertension in an Animal Model of Obstructive Sleep Apnea, Journal of the American College of Cardiology, vol.53, issue.15, pp.1309-1317, 2009.
DOI : 10.1016/j.jacc.2008.12.050

J. Pernow, «Endothelin in myocardial ischemia and reperfusion,» Cardiovascular research, pp.518-526, 1997.

A. Bouallegue, «Endothelin-1-induced signaling pathways in vascular smooth muscle cells,» Current Vascular pharmacology, pp.45-52, 2007.

S. Tamareille, Endothelin-1 Release during the Early Phase of Reperfusion Is a Mediator of Myocardial Reperfusion Injury, Cardiology, vol.125, issue.4, pp.242-249, 2013.
DOI : 10.1159/000350655

J. Hu, «Hypoxia regulates expression of the endothelin-1 gene through a proximal Hypoxiainducible Factor-1 binding site on the antisense strand,» Biochemical and biophysical research communications, pp.894-899, 1998.

K. Yamashita, «Molecular regulation of the endothelin-1 gene by hypoxia,» The journal of biological chemistry, pp.12645-12653, 2001.

I. Wieczorek, Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome., Heart, vol.72, issue.5, pp.436-441, 1994.
DOI : 10.1136/hrt.72.5.436

T. Watanabe, Contribution of endogenous endothelin to the extension of myocardial infarct size in rats, Circulation Research, vol.69, issue.2, pp.370-377, 1991.
DOI : 10.1161/01.RES.69.2.370

X. T. Gan, Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation, Canadian Journal of Physiology and Pharmacology, vol.91, issue.1, pp.105-113, 2003.
DOI : 10.1161/01.CIR.91.4.941

N. L. Kanagy, Role of Endothelin in Intermittent Hypoxia-Induced Hypertension, Hypertension, vol.37, issue.2, pp.511-515, 2001.
DOI : 10.1161/01.HYP.37.2.511

A. D. Singh, Cardioprotective Effects of Bosentan, a Mixed Endothelin Type A and B Receptor Antagonist, during Myocardial Ischaemia and Reperfusion in Rats, Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, vol.42, issue.6, pp.604-610, 2006.
DOI : 10.1053/euhj.2001.2901

R. Ozdemir, Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury, Toxicology, vol.219, issue.1-3, pp.142-149, 2006.
DOI : 10.1016/j.tox.2005.11.022

Z. Wang, CPU0213, a novel endothelin type A and type B receptor antagonist, protects against myocardial ischemia/reperfusion injury in rats, Brazilian Journal of Medical and Biological Research, vol.47, issue.11, pp.1148-1155, 2011.
DOI : 10.1080/10715760500073840

E. Belaidi, Endoplasmic reticulum stress as a novel inducer of hypoxia inducible factor-1 activity: its role in the susceptibility to myocardial ischemia???reperfusion induced by chronic intermittent hypoxia, International Journal of Cardiology, vol.210, pp.45-53, 2016.
DOI : 10.1016/j.ijcard.2016.02.096

J. Groenendyk, Biology of Endoplasmic Reticulum Stress in the Heart, Circulation Research, vol.107, issue.10, 2010.
DOI : 10.1161/CIRCRESAHA.110.227033

G. Bourdier, High-intensity training reduces intermittent hypoxia-induced ER stress and myocardial infarct size, American Journal of Physiology - Heart and Circulatory Physiology, vol.310, issue.2, pp.279-289, 2016.
DOI : 10.1152/ajpheart.00448.2015

URL : http://ajpheart.physiology.org/content/ajpheart/310/2/H279.full.pdf